Antitumor activity of interferon-β1a in hormone refractory prostate cancer with neuroendocrine differentiation.

A DicitoreE S GrassiM O BorghiG GelminiM C CantoneG GaudenziL PersaniM CaragliaGiovanna Mantovani

Published in: Journal of endocrinological investigation (2017)

Recombinant IFN-β1a (Rebif) showed a potent in vitro anti-proliferative activity in androgen-resistant prostate cancer cells, and it could represent a promising tool for the treatment of this tumor.

Keyphrases

prostate cancer
dendritic cells
radical prostatectomy
immune response
smoking cessation